Browse Category

Investment Insights News 9 December 2025 - 10 December 2025

SGX Biggest Losers Today (10 December 2025): Clearbridge Health, Sevens Atelier and Spackman Lead Sell-Off

SGX Biggest Losers Today (10 December 2025): Clearbridge Health, Sevens Atelier and Spackman Lead Sell-Off

Singapore’s stock market spent Wednesday under mild pressure as global investors hunkered down ahead of a closely watched US Federal Reserve decision — but beneath the relatively calm Straits Times Index, a cluster of small-cap counters on the Singapore Exchange (SGX) suffered double‑digit losses. As of around 1.50pm SGT on 10 December 2025, SGinvestors’ Top Losers (%) board showed Clearbridge…
Lumentum Holdings (LITE) After-Hours Surge on December 9, 2025: AI Boom, Lofty Valuations, and What to Watch Before the December 10 Open

Lumentum Holdings (LITE) After-Hours Surge on December 9, 2025: AI Boom, Lofty Valuations, and What to Watch Before the December 10 Open

Lumentum Holdings Inc. (NASDAQ: LITE) extended its powerful 2025 rally on Tuesday, December 9, with shares pushing to fresh record territory and holding up in after-hours trading. The move capped a day dominated by optimism around AI data‑center infrastructure, even as more analysts warn that the stock’s valuation is starting to look stretched. Below is a data‑driven look at how…
Salesforce (CRM) After Hours on December 9, 2025: AI Momentum, Analyst Moves and What to Watch Before the December 10 Open

Salesforce (CRM) After Hours on December 9, 2025: AI Momentum, Analyst Moves and What to Watch Before the December 10 Open

Salesforce, Inc. (NYSE: CRM) ended Tuesday, December 9, 2025, quietly but firmly in the green, as investors continued to digest a big AI-fueled earnings beat and a fresh wave of Wall Street research. With U.S. markets set to reopen on Wednesday, December 10, traders and longer-term investors alike are asking the same question: what does all of this mean for…
JPMorgan Chase (JPM) Stock Slides on $105 Billion Expense Warning: What to Know After the Bell on December 9, 2025 and Before the Market Opens December 10

JPMorgan Chase (JPM) Stock Slides on $105 Billion Expense Warning: What to Know After the Bell on December 9, 2025 and Before the Market Opens December 10

JPMorgan Chase & Co. (NYSE: JPM) shook U.S. markets on Tuesday, December 9, 2025, after management told investors to expect significantly higher expenses in 2026 and flagged a “more fragile” consumer backdrop. The stock closed at $300.51, down about 4.7% on the day, making it the worst performer in the Dow Jones Industrial Average and one of the biggest drags…
Oracle Stock After Hours on December 9, 2025: Earnings Preview and 7 Things to Know Before the December 10 Open

Oracle Stock After Hours on December 9, 2025: Earnings Preview and 7 Things to Know Before the December 10 Open

Oracle Corporation (NYSE: ORCL) heads into one of its most important trading days of the year with its share price stabilizing in the low $220s and Wall Street laser‑focused on AI cloud growth, debt, and the Federal Reserve’s rate decision. The company will report fiscal Q2 2026 results after the U.S. market close on Wednesday, December 10, 2025, with its…
Alphabet (GOOG) After Hours on December 9, 2025: EU AI Probe, $400 Targets and What to Watch Before the December 10 Open

Alphabet (GOOG) After Hours on December 9, 2025: EU AI Probe, $400 Targets and What to Watch Before the December 10 Open

Alphabet Inc.’s Class C shares (NASDAQ: GOOG) finished Tuesday, December 9, 2025 near record territory and then edged slightly higher in after-hours trading, even as a new EU antitrust probe and a final U.S. search ruling injected fresh regulatory risk into the Google story.TechStock²+1 Below is a detailed look at how Alphabet stock traded after the bell, the biggest news…
Eli Lilly Stock (LLY) on December 9, 2025: Price, Alabama Megaplant, Jaypirca Breakthrough and 2026–2030 Forecasts

Eli Lilly Stock (LLY) on December 9, 2025: Price, Alabama Megaplant, Jaypirca Breakthrough and 2026–2030 Forecasts

As of Tuesday, December 9, 2025, Eli Lilly (NYSE: LLY) sits at the center of nearly every conversation about obesity drugs, oncology breakthroughs and “next trillion‑dollar” stocks. The shares trade around $980 per share, down about 1.6% on the day but still roughly 57% above their 52‑week lowand about 12% below the recent record high of $1,111.99 set in late November.StockAnalysis+1 That puts Lilly’s market…
Silver Price Today, December 9, 2025: Spot Silver Smashes $60 Record as Fed Decision Looms

Silver Price Today, December 9, 2025: Spot Silver Smashes $60 Record as Fed Decision Looms

Silver just made history. On December 9, 2025, the spot silver price burst above $60 per ounce for the first time ever, capping a stunning rally that has roughly doubled the metal’s value in 2025 and left even gold behind. Major outlets from Reuters and Bloomberg to the Financial Times, Mining.com and The Washington Post all confirm that silver is now trading in uncharted…
Visa Stock (V) Today: HSBC Upgrade, New Partnerships and 2026 Outlook for the Payments Giant

Visa Stock (V) Today: HSBC Upgrade, New Partnerships and 2026 Outlook for the Payments Giant

Published: December 9, 2025 – All data and news as of U.S. afternoon trading on this date. Visa stock snapshot on 9 December 2025 Visa Inc. (NYSE: V) is trading roughly flat to slightly lower today, around $325–$328 per share, down about 0.3% intraday. That implies a market capitalization in the $590–630 billion range, with the shares still near the…
KE Holdings (BEKE) Stock Slides as Buybacks Accelerate: What Q3 2025 Earnings and China’s Housing Slump Mean for Investors

KE Holdings (BEKE) Stock Slides as Buybacks Accelerate: What Q3 2025 Earnings and China’s Housing Slump Mean for Investors

Published 9 December 2025 KE Holdings Inc. (NYSE: BEKE), the Chinese online and offline housing platform behind Lianjia and Beike, is back in the spotlight as its stock trades lower today despite aggressive share repurchases and steady revenue growth. On Tuesday, BEKE gapped down at the open, sliding from a previous close of about $17.08 to an open near $16.35,…
Praxis Precision Medicines (PRAX) Soars on FDA Momentum and 760-Dollar Target: December 9, 2025 Stock Deep Dive

Praxis Precision Medicines (PRAX) Soars on FDA Momentum and 760-Dollar Target: December 9, 2025 Stock Deep Dive

Praxis Precision Medicines, Inc. (NASDAQ: PRAX) has turned into one of 2025’s most dramatic biotech stories. On December 9, 2025, the stock is trading around $265–270 per share, near its 52‑week high of about $278 and far above its low near $26.70, giving the company a market capitalization of roughly $6.6 billion.StockAnalysis+1 Behind that move is a mix of powerful…
Top Gainers on the US Stock Market Today (December 9, 2025): AFJK, NCPL, XCUR, ALEX and More Surge as Fed Meeting Looms

Top Gainers on the US Stock Market Today (December 9, 2025): AFJK, NCPL, XCUR, ALEX and More Surge as Fed Meeting Looms

US stocks spent Tuesday in a cautious, sideways mood as traders waited for the Federal Reserve’s final interest‑rate decision of 2025. The Dow inched higher, the S&P 500 was roughly flat, and the Nasdaq drifted slightly lower, even as expectations hardened around another rate cut and a closely watched press conference from Fed Chair Jerome Powell. Investopedia+3StockAnalysis+3Yahoo Finance+3 Beneath the…
1 43 44 45 46 47 66

Stock Market Today

  • Strathcona Resources Shares Fall Below 50-Day Moving Average Amid Mixed Analyst Ratings
    February 6, 2026, 12:10 PM EST. Shares of Strathcona Resources Ltd. (TSE:SCR) dropped below its 50-day moving average of C$32.28, trading as low as C$26.53. The stock last traded at C$27.15 on Thursday, with 287,608 shares changing hands. Analyst opinions vary: TD Securities and National Bank of Canada issue bullish outlooks with target prices of C$36.00 and strong-buy ratings, while Royal Bank of Canada and Jefferies suggest more cautious views. The company recently paid a quarterly dividend of C$0.30, yielding 4.4%. Strathcona Resources, a Canadian oil and gas producer focused on thermal oil and enhanced recovery, holds a market cap of C$5.87 billion. Its price-to-earnings ratio stands at 5.35, with a high beta of 2.61, indicating increased volatility.
Go toTop